基础医学与临床 ›› 2019, Vol. 39 ›› Issue (4): 564-568.
• 短篇综述 • 上一篇 下一篇
俞源源,刘映红,袁芳
收稿日期:
修回日期:
出版日期:
发布日期:
通讯作者:
基金资助:
Received:
Revised:
Online:
Published:
摘要: 炎性小体是胞质内的一组多蛋白复合体,一方面它能调节半胱氨酸天冬氨酸特异蛋白酶 1 的活化,促进IL-1β 和 IL-18 成熟与分泌,引起炎性反应;另一方面可以引起细胞焦亡。NLRC4炎性小体的主要信号途径为:激活物(如细菌鞭毛蛋白),感应蛋白(NAIP),核效应蛋白(NLRC4),连接蛋白(ASC),效应蛋白。NLRC4活化的主要调控机制是:配体结合机制和磷酸化作用。NLRC4是肠道免疫的重要组成成分,可抵御多种病原体,并与多种人类疾病相关:如自身炎性疾病、糖尿病肾病、胸腺癌等。
关键词: 关键词:NLRC4炎症小体, 炎症反应, 自身炎症疾病
Abstract: Inflammasomes are cytosolic multiprotein complexes that can regulate the activation of caspase-1, promote the maturation and secretion of IL-1β and IL-18,and lead to inflammation ,meanwhile initiate pyroptosis. The classic illustration of the NLRC4 inflammasome paradigm is: trigger (e.g. cytosolic flagellin), sensor (NAIP), nucleator (NLRC4), adaptor (ASC), and effector (caspase-1). The main regulatory mechanisms of NLRC4 activation are ligand binding and phosphorylation. NLRC4 is a critical component of intestinal immune system and defense against different pathogens. In addition,NLRC4 related to a variety of human diseases: such as autoinflammatory diseases, diabetic nephropathy, thymic cancer.
Key words: Keywords: NLRC4 Inflammasome, Inflammation,, Autoinflammation Diseases
俞源源 刘映红 袁芳. NLRC4炎性小体的研究进展[J]. 基础医学与临床, 2019, 39(4): 564-568.
/ 推荐
导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文: https://journal11.magtechjournal.com/Jwk_jcyxylc/CN/
https://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2019/V39/I4/564